Eli Lilly & Co. (LLY)

Eli Lilly & Co., adjusted current assets

USD $ in thousands

		Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
	As Reported
	Current assets
	Adjustments
	Add: Allowances
	Add: LIFO reserve1
	After Adjustment
	Adjusted current assets

Based on: 10-K (filing date: 2019-02-19), 10-K (filing date: 2018-02-20), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-19).

Eli Lilly & Co., adjusted total assets

USD $ in thousands

		Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
	As Reported
	Total assets
	Adjustments
	Add: Operating leased assets1
	Add: Allowances
	Add: LIFO reserve2
	Less: Deferred tax assets3
	After Adjustment
	Adjusted total assets

Based on: 10-K (filing date: 2019-02-19), 10-K (filing date: 2018-02-20), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-19).

Eli Lilly & Co., adjusted current liabilities

USD $ in thousands

		Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
	As Reported
	Current liabilities
	Adjustments
	Less: Deferred income taxes1
	After Adjustment
	Adjusted current liabilities

Based on: 10-K (filing date: 2019-02-19), 10-K (filing date: 2018-02-20), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-19).

Eli Lilly & Co., adjusted total liabilities

USD $ in thousands

		Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
	As Reported
	Total liabilities
	Adjustments
	Add: Operating lease obligations1
	Less: Deferred income taxes2
	After Adjustment
	Adjusted total liabilities

Based on: 10-K (filing date: 2019-02-19), 10-K (filing date: 2018-02-20), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-19).

Eli Lilly & Co., adjusted total Eli Lilly and Company shareholders’ equity

USD $ in thousands

		Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
	As Reported
	Total Eli Lilly and Company shareholders’ equity
	Adjustments
	Less: Deferred tax assets (liabilities), net1
	Add: Allowances
	Add: LIFO reserve2
	Add: Noncontrolling interests
	After Adjustment
	Adjusted total Eli Lilly and Company shareholders’ equity

Based on: 10-K (filing date: 2019-02-19), 10-K (filing date: 2018-02-20), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-19).

Eli Lilly & Co., adjusted capitalization table

USD $ in thousands

		Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
	As Reported
	Short-term borrowings and current maturities of long-term debt
	Long-term debt, excluding current maturities
	Total reported debt
	Total Eli Lilly and Company shareholders’ equity
	Total reported capital
	Adjustments to Debt
	Add: Operating lease obligations1
	Adjusted total debt
	Adjustments to Equity
	Less: Deferred tax assets (liabilities), net2
	Add: Allowances
	Add: LIFO reserve3
	Add: Noncontrolling interests
	Adjusted total Eli Lilly and Company shareholders’ equity
	After Adjustment
	Adjusted total capital

Based on: 10-K (filing date: 2019-02-19), 10-K (filing date: 2018-02-20), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-19).

Eli Lilly & Co., adjusted net income (loss)

USD $ in thousands

	12 months ended	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
	As Reported
	Net income (loss)
	Adjustments
	Add: Deferred income tax expense (benefit)1
	Add: Increase (decrease) in allowances
	Add: Increase (decrease) in LIFO reserve2
	Add: Other comprehensive income (loss)
	After Adjustment
	Adjusted net income (loss)

Based on: 10-K (filing date: 2019-02-19), 10-K (filing date: 2018-02-20), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-19).